MARKET

NGEN

NGEN

Nervgen Pharma Corp
NASDAQ
1.350
+0.030
+2.27%
Closed 16:10 11/04 EST
OPEN
1.360
PREV CLOSE
1.320
HIGH
1.380
LOW
1.306
VOLUME
224.39K
TURNOVER
153.36K
52 WEEK HIGH
6.30
52 WEEK LOW
1.280
MARKET CAP
145.28M
P/E (TTM)
-2.5234
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NGEN last week (1026-1030)?
Weekly Report · 3d ago
Weekly Report: what happened at NGEN last week (1019-1023)?
Weekly Report · 10/26 09:05
Weekly Report: what happened at NGEN last week (1012-1016)?
Weekly Report · 10/19 09:05
NervGen Pharma doses first participant in RESTORE trial
TipRanks · 10/12 11:20
NervGen Doses First Participant In Phase 3 RESTORE Study Of NVG-291 For Chronic Cervical SCI; Enrollment Completion Expected In H2 2027, Topline Data In H1 2028
Benzinga · 10/12 11:17
Weekly Report: what happened at NGEN last week (1005-1009)?
Weekly Report · 10/12 09:05
Weekly Report: what happened at NGEN last week (0928-1002)?
Weekly Report · 10/05 09:05
NervGen Pharma: The Upside Is Large, But Phase 3 Decides Everything
Seeking Alpha · 10/01 21:26
More
About NGEN
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.

Webull offers NervGen Pharma Corp stock information, including NASDAQ: NGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NGEN stock methods without spending real money on the virtual paper trading platform.